Literature DB >> 22175889

Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.

Jing Xu1, Motoko Sasaki, Kenichi Harada, Yasunori Sato, Hiroko Ikeda, Ji-Hun Kim, Eunsil Yu, Yasuni Nakanuma.   

Abstract

AIMS: Intrahepatic cholangiocarcinomas (ICCs) are known to arise in cases of non-biliary, chronic advanced liver disease (CALD), but their clinicopathological features remain unexplored. The aim of this study was to compare the histological and immunohistochemical ICCs arising inCALD with those arising in livers with non-specific reactive (NSR) changes. METHODS AND
RESULTS: Seventy-one cases of ICC arising in CALD were compared with ICCs arising in livers with NSR changes, including normal livers (72 cases) and the cholangiocarcinomatous (CC) component of hepatocellular cholangioncarcinomas (HC-CCs) (30 cases). The expression of mucin was higher in ICC with NSR changes, whereas it was relatively low in ICC with CALD and the CC component of HC-CC. The expression of biliary markers [cytokeratin (CK)7, CK19, epithelial membrane antigen, and epithelial cell adhesion molecule (EpCAM)] was lower in CC with CALD and in the CC component of HC-CC than in CC with NSR changes. The expression of hepatic progenitor cell markers [neural cell adhesion molecule (NCAM) and c-kit] was higher in ICC with CALD and the CC component of HC-CC than in ICC with NSR changes. EpCAM and CK19 were constantly expressed in cultured CC cells, whereas NCAM was infrequently expressed in cultured CC cells.
CONCLUSIONS: The carcinogenesis of ICC arising in CALD and the ICC component of HC-CC, each showing similar features, may involve hepatic progenitor cells.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175889     DOI: 10.1111/j.1365-2559.2011.04058.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report.

Authors:  Rongxing Zhou; Minjia Zhang; Nansheng Cheng; Yong Zhou
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

2.  Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.

Authors:  Elisabetta Sagrini; Massimo Iavarone; Federico Stefanini; Francesco Tovoli; Sara Vavassori; Marco Maggioni; Matteo Renzulli; Veronica Salvatore; Horia Stefanescu; Massimo Colombo; Luigi Bolondi; Fabio Piscaglia
Journal:  United European Gastroenterol J       Date:  2018-11-22       Impact factor: 4.623

3.  Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.

Authors:  Elena Panettieri; Harufumi Maki; Bradford J Kim; HyunSeon Christine Kang; Veronica Cox; Eduardo A Vega; Takashi Mizuno; Shubham Pant; Milind Javle; Jean-Nicolas Vauthey; Yoshikuni Kawaguchi
Journal:  Surg Oncol       Date:  2021-12-31       Impact factor: 3.279

Review 4.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

5.  Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy?

Authors:  Chen Jin; Xiao-Yun Zhang; Jia-Wu Li; Chuan Li; Wei Peng; Tian-Fu Wen; Yan Luo; Qiang Lu; Xiao-Fei Zhong; Jing-Yi Zhang; Lv-Nan Yan; Jia-Yin Yang
Journal:  Oncotarget       Date:  2017-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.